BRPI0412342A - compostos esteróides de tiomorfolino, uso dos mesmos para a preparação de medicamentos reguladores de meiose e método para a preparação dos mesmos - Google Patents
compostos esteróides de tiomorfolino, uso dos mesmos para a preparação de medicamentos reguladores de meiose e método para a preparação dos mesmosInfo
- Publication number
- BRPI0412342A BRPI0412342A BRPI0412342-5A BRPI0412342A BRPI0412342A BR PI0412342 A BRPI0412342 A BR PI0412342A BR PI0412342 A BRPI0412342 A BR PI0412342A BR PI0412342 A BRPI0412342 A BR PI0412342A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- thiomorpholino
- steroid compounds
- medicinal products
- regulating medicinal
- Prior art date
Links
- 230000021121 meiosis Effects 0.000 title abstract 2
- -1 thiomorpholino steroid compounds Chemical class 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 150000003431 steroids Chemical class 0.000 abstract 2
- 210000000287 oocyte Anatomy 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 125000005505 thiomorpholino group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"COMPOSTOS ESTERóIDES DE TIOMORFOLINO, USO DOS MESMOS PARA A PREPARAçãO DE MEDICAMENTOS REGULADORES DE MEIOSE E MéTODO PARA A PREPARAçãO DOS MESMOS". A presente invenção refere-se a compostos esteróides de tiomorfolino de fórmula geral (I), que podem ser vantajosamente empregados para estimular a meiose em oócitos humanos, o esteróide sendo especificamente caracterizado por uma porção tiomorfolino ligada ao C¬ 17¬ do esqueleto do esteróide via um espaçador do tipo alquileno.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03090237A EP1514874A1 (en) | 2003-07-28 | 2003-07-28 | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof |
| PCT/EP2004/007737 WO2005014613A1 (en) | 2003-07-28 | 2004-07-13 | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0412342A true BRPI0412342A (pt) | 2006-09-05 |
Family
ID=34130263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0412342-5A BRPI0412342A (pt) | 2003-07-28 | 2004-07-13 | compostos esteróides de tiomorfolino, uso dos mesmos para a preparação de medicamentos reguladores de meiose e método para a preparação dos mesmos |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070078262A1 (pt) |
| EP (2) | EP1514874A1 (pt) |
| JP (1) | JP2007500140A (pt) |
| KR (1) | KR20060059991A (pt) |
| CN (1) | CN1829731A (pt) |
| AT (1) | ATE393772T1 (pt) |
| AU (1) | AU2004263252A1 (pt) |
| BR (1) | BRPI0412342A (pt) |
| CA (1) | CA2528904A1 (pt) |
| DE (1) | DE602004013453T2 (pt) |
| DK (1) | DK1664079T3 (pt) |
| ES (1) | ES2305813T3 (pt) |
| IL (1) | IL172085A0 (pt) |
| NO (1) | NO20060936L (pt) |
| PL (1) | PL1664079T3 (pt) |
| PT (1) | PT1664079E (pt) |
| RU (1) | RU2349597C2 (pt) |
| WO (1) | WO2005014613A1 (pt) |
| ZA (1) | ZA200601711B (pt) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2813094A (en) * | 1955-02-16 | 1957-11-12 | Searle & Co | Cyclic derivatives of 3-hydroxy-delta-pregnene-20-carboxamide |
| US2846432A (en) * | 1957-10-31 | 1958-08-05 | Searle & Co | Heterocyclic derivatives of 20-amino-methyl-5-pregnen-3-ol |
| DE1930473A1 (de) * | 1969-06-14 | 1970-12-17 | Schering Ag | 22-N-substituierte (20R)-23,24-dinor-cholanderivate |
| US3983111A (en) * | 1972-05-05 | 1976-09-28 | Glaxo Laboratories Limited | Steroidal anaesthetics of the pregnane and 19-norpregnane series |
| GB9804861D0 (en) * | 1998-03-06 | 1998-04-29 | Res Inst Medicine Chem | Chemical compounds |
| EP1245572A1 (en) * | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
-
2003
- 2003-07-28 EP EP03090237A patent/EP1514874A1/en not_active Withdrawn
-
2004
- 2004-07-13 BR BRPI0412342-5A patent/BRPI0412342A/pt not_active IP Right Cessation
- 2004-07-13 CA CA002528904A patent/CA2528904A1/en not_active Abandoned
- 2004-07-13 PL PL04763197T patent/PL1664079T3/pl unknown
- 2004-07-13 DK DK04763197T patent/DK1664079T3/da active
- 2004-07-13 AT AT04763197T patent/ATE393772T1/de not_active IP Right Cessation
- 2004-07-13 EP EP04763197A patent/EP1664079B1/en not_active Expired - Lifetime
- 2004-07-13 JP JP2006521437A patent/JP2007500140A/ja active Pending
- 2004-07-13 ES ES04763197T patent/ES2305813T3/es not_active Expired - Lifetime
- 2004-07-13 CN CNA2004800215690A patent/CN1829731A/zh active Pending
- 2004-07-13 PT PT04763197T patent/PT1664079E/pt unknown
- 2004-07-13 KR KR1020067002053A patent/KR20060059991A/ko not_active Withdrawn
- 2004-07-13 WO PCT/EP2004/007737 patent/WO2005014613A1/en not_active Ceased
- 2004-07-13 US US10/566,282 patent/US20070078262A1/en not_active Abandoned
- 2004-07-13 AU AU2004263252A patent/AU2004263252A1/en not_active Abandoned
- 2004-07-13 DE DE602004013453T patent/DE602004013453T2/de not_active Expired - Fee Related
- 2004-07-13 RU RU2006105783/04A patent/RU2349597C2/ru not_active IP Right Cessation
-
2005
- 2005-11-21 IL IL172085A patent/IL172085A0/en unknown
-
2006
- 2006-02-27 NO NO20060936A patent/NO20060936L/no not_active Application Discontinuation
- 2006-02-27 ZA ZA200601711A patent/ZA200601711B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1664079B1 (en) | 2008-04-30 |
| CN1829731A (zh) | 2006-09-06 |
| WO2005014613A1 (en) | 2005-02-17 |
| US20070078262A1 (en) | 2007-04-05 |
| DE602004013453T2 (de) | 2009-06-18 |
| NO20060936L (no) | 2006-02-27 |
| PT1664079E (pt) | 2008-07-14 |
| ZA200601711B (en) | 2007-05-30 |
| DE602004013453D1 (de) | 2008-06-12 |
| PL1664079T3 (pl) | 2008-09-30 |
| EP1664079A1 (en) | 2006-06-07 |
| RU2349597C2 (ru) | 2009-03-20 |
| ES2305813T3 (es) | 2008-11-01 |
| IL172085A0 (en) | 2009-02-11 |
| ATE393772T1 (de) | 2008-05-15 |
| CA2528904A1 (en) | 2005-02-17 |
| KR20060059991A (ko) | 2006-06-02 |
| EP1514874A1 (en) | 2005-03-16 |
| AU2004263252A1 (en) | 2005-02-17 |
| JP2007500140A (ja) | 2007-01-11 |
| RU2006105783A (ru) | 2007-09-20 |
| DK1664079T3 (da) | 2008-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE417610T1 (de) | Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen | |
| UY28369A1 (es) | Agentes terapéuticos | |
| UY28376A1 (es) | Agentes terapéuticos | |
| BRPI0411582A (pt) | substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso | |
| PA8609201A1 (es) | Piridinonas sustituidas | |
| BRPI0610850A2 (pt) | derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados | |
| UY32682A (es) | "derivados de 1h-imidazo-[4,5-c]-quinolinona" | |
| BRPI0516483A (pt) | preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade | |
| AR047529A1 (es) | Compuestos de quinolina sustituidos | |
| BRPI0410170A (pt) | preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade | |
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| BR0308784A (pt) | Miméticos de glucocorticóides, métodos para fabricar os mesmos, composições farmacêuticas e usos dos mesmos | |
| ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| MX2009003958A (es) | Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso. | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| UY32691A (es) | Compuestos de 1h-imidazo-[4,5-c]-quinolinona | |
| EA201000436A1 (ru) | Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| CR9182A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene | |
| UY28377A1 (es) | Agentes terapeuticos | |
| ECSP088250A (es) | Derivados de pirazol como agentes terapéuticos | |
| BR0311491A (pt) | Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero | |
| SE0401763D0 (sv) | Compounds | |
| UY28839A1 (es) | Agentes terapeuticos | |
| DE502006004182D1 (de) | Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2-aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADE(S) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |